News

Tue, 13/06/2017

New Mark and Mitelos agree to market the therapeutic alternative for treating impacted ear wax OTIBLOCK

Tue, 28/02/2017

WASHDENT is a food supplement, developed by Mitelos, that complements your dental hygiene routine at any time or place, when a more complete clean is not possible.

Tue, 31/01/2017

Madrid, 31 January, 2017.- Mylan and Mitelos have signed a collaboration agreement to provide Zelium to patients in Spain. Zelium is a medical device that provides therapeutic alternative to prevent the complications of diabetic foot, and that will be available soon in Spain. The diabetic foot is the result of complications of diabetes mellitus when the disease is not well controlled.

Wed, 21/09/2016

September 20, 2016.-Faes and Mitelos will make OtiFaes Taponox® available to doctors and patients.This represents a therapeutic alternative for treating impacted ear wax. OtiFaes Taponox® otic spray helps to remove impacted ear wax from the ear canal thanks to its formulation, which is oil-free and helps the ear to maintain the proper pH. OtiFaes Taponox® which is due to go on sale by Faes Farma, has been developed, registered and manufactured by Mitelos.

Thu, 03/12/2015

Palma de Mallorca and Cerdanyola del Vallès, Spain, December 1, 2015.- Sanifit and Mitelos have successfully concluded the development, registration and industrial scaled up of SNF671, a breakthrough patent protected dietary supplement to prevent osteoporosis within postmenopausal women, which was originated at the Laboratory of Renal Lithiasis Research of the University of the Balearic Islands.

Tue, 28/04/2015

Cerdanyola del Vallès (Barcelona), April 28th, 2015.- Mitelos has recently concluded a cooperation agreement with a company located in San Francisco Bay area, California, in order to offer a correspondent business development services provider with U.S. Market coverage.

Sat, 14/02/2015

Barcelona, February 13th, 2015.-  Mitelos is pleased to announce that it has acted as advisor to one of the leading European laboratories within the areas of fertility, gynaecology and endocrinology to expand its business towards Latin America.

Tue, 27/01/2015

Barcelona, January 27th, 2015.- Mitelos, a privately owned company, started its activities in March 2013, focused on the development of new added-value products to address conditions with high prevalence. 

Mon, 20/10/2014

Barcelona, October 20th, 2014.- Mitelos has announced the results of the clinical study conducted with its nutraceutical VIGISLEEP®.